Summary and Key Points
1. Adenocarcinoma of the endometrium is the most common gynecologic malignancy in the United States. 2. Because abnormal vaginal bleeding is a common initial symptom of endometrial cancer, most cancers are discovered at an early stage. 3. Endometrial adenocarcinoma is associated with a variety of risk factors, many of which are marked by a state of elevated or prolonged exposure to estrogens. 4. Lower grade, or Type 1, endometrial cancers are most strongly associated with excessive estrogen exposure. 5. Higher grade, or Type 2, endometrial cancers have a greater risk of relapse or systemic spread than Type 1 tumors. 6. Surgical resection, a hysterectomy and removal of the ovaries plus/minus pelvic and paraaortic lymphadenectomy, is the foundation of treatment of endometrial cancer. Patients at high risk for local/regional recurrence receive adjuvant radiotherapy. Medically inoperable patients receive primary radiotherapy and or hormonal therapy. 7. Sarcomas of the uterus also occur, but are uncommon.
Leiomyosarcomas are aggressive tumors, and endometrial stromal sarcomas are likely to behave in an indolent fashion. 8. Serous and clear cell carcinomas are rare but aggressive type of endometrial cancer.
Epidemiology
Endometrial adenocarcinoma is the most common gynecologic malignancy in the United States and the fourth most common malignancy in women overall. The American Cancer Society (ACS) data for endometrial cancer in the United States estimates that more Atypical endometrial hyperplasia is considered a precursor lesion to endometrial cancer. Endometrial hyperplasia occurs as a continuum from simple to complex ( Figure 2 ), and may progress to an invasive endometrial cancer if left untreated. 6 Atypical endometrial hyperplasia is usually treated with a hysterectomy, unless a woman desires childbearing in which case progestin therapy and close monitoring is offered. When childbearing is completed a hysterectomy is usually recommended. 7 Figure 2 . This image shows mostly endometrial complex hyperplasia with only few foci of well differentiated adenocarcinoma, endometrioid type. The hyperplastic glands are tightly crowded, but still separate from each other by a very thin strand of stromal tissue. In the adenocarcinoma foci we start 
Histological Types Of Endometrial Cancer
Cancers of the uterus originate from either (1) A section taken from the endometrial mass shows many neoplastic glands invade deep into the myometrium. Because these glands resemble normal proliferative endometrial glands, this type of cancer is called endometrioid type. On the other hand, these glands are malignant, not benign, mainly because of their complex architecture and infiltrating growth pattern. Endometrioid adenocarcinoma is the most common type of endometrial carcinoma. It is estrogen-dependent, which is also known as "type I" endometrial cancer. Courtesy of University of Massachusetts Medical School, Department of Pathology, UMass Memorial Medical Center. 
Endometrial Carcinoma Grading
The grading of this cancer is done on a scale of 1 to 3 based on the amount of solid growth and nuclear atypia present.
Endometrial Carcinoma Prognostic Typing
Endometrial cancers are often further categorized, based on underlying causes and prognosis, into a Type 1 or Type 2 cancer.
Type 1 is thought to be caused by excess estrogen, is usually not aggressive and is slow to metastasize or spread to contiguous tissues. Grade 1 (Figure 11 ) and Grade 2 endometrioid cancers ( Figure 12 ) are examples of Type 1 endometrial cancers. 
Uterine Sarcomas
Sarcomas comprise about 3% of uterine cancers. Technically, they are NOT endometrial cancers, since they arise from the myometrial wall. They also often present with abnormal uterine bleeding, but some tumors are found because of pelvic masses. Leiomyomas (fibroids) ( Figure 13 ) are quite common, completely benign ( Figure 14) and often resected if symptomatic ( Figure 15 ). 
Management of Endometrial Cancer
Watch the first two and last two minutes of this YouTube movie Tumor extends to the adjacent organs but not the bladder and rectal mucosa or involves the regional lymph nodes Stage 4
Tumor metastasize to the distant organs
Thought Questions
1. Estrogen can increase the risk of endometrial cancer, particularly Type 1 tumors. Tamoxifen, a selective estrogen receptor modulator, lowers a post-menopausal woman's risk of developing an estrogen receptor positive breast cancer by 40%, but increases the risk of developing endometrial cancer by 300%. Think of ways that Tamoxifen can reduce the risk of an estrogen-associated cancer in one organ, but increase the risk in another.
Expert Answer
Your answer: 
Glossary
Cribriforming pattern-A sieve like histologic appearance Nulliparity-The state of never having been pregnant Polycystic ovary disease (Stein-Leventhal Syndrome)-An endocrine disorder with enlarged ovaries with small collections of fluid, folliclesbest seen on ultrasound or CT, associated with infrequent or prolonged menses, infertility, excess hair growth, acne, and obesity.
Unopposed estrogen exposure-Estrogen exposure without progesterone exposure
